AIVF and Genea Biomedx enter a partnership to jolt the $50B IVF Market.

MedCity News. Why AI is the solution for IVF accessibility

Pam Schwartz | Sep 5, 2022

Daniella Gilboa, AIVF CEO, discusses how technology and, more specifically, artificial intelligence (AI) is the missing piece that will springboard IVF into the modern digital age. By augmenting the embryologist in selecting the most viable embryo, there is potential for AI to help an individual conceive in one or two cycles, reducing the cost of IVF and making the treatment more accessible to diverse populations that often don’t have ease of access to treatments today.

Read the article on MedCity News.